wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28075244-1073B080-9617-479D-A4BD-9A2B73A462E4
Q28075244-1073B080-9617-479D-A4BD-9A2B73A462E4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28075244-1073B080-9617-479D-A4BD-9A2B73A462E4
ErbB2 signaling at the crossing between heart failure and cancer
P2860
Q28075244-1073B080-9617-479D-A4BD-9A2B73A462E4
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28075244-1073B080-9617-479D-A4BD-9A2B73A462E4
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
1bc90ad378ec77e3ab016a42aac00cebef82198f
P2860
A phase II study of afatinib (BIBW 2992), an irreversible ErbB family blocker, in patients with HER2-positive metastatic breast cancer progressing after trastuzumab